Pharmaceutical formulation comprising ciclesonide

US11819549B2 · kind B2 · utility

Inventors

• Michael Aven · Mainz, DE
• Benjamin Franzmann · Merxheim, DE
• Matthias Hausmann · Rees, DE

Key dates

• Filing date: Dec 23, 2020
• Grant date: Nov 21, 2023
• Expiry date: Jan 4, 2042

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P11/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.